Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of mesenchymal stem cells on healing of foot ulcers in diabetes patients
2023-505961-10-00Phase 2Completed
- Sponsor
- Cell to Cure
- Start
- Jul 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cells in diabetic foot ulcer (DFU) and type 2 diabetes mellitus (T2DM), sponsored by Cell to Cure. Started Jul 2023; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
diabetic foot ulcer (DFU)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2023-505961-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505961-10-00.